Medications

FDA approves drug combo for metastatic non-small cell lung cancer

The U.S. Food and Drug Administration approved the combination of tremelimumab (Imjudo) plus durvalumab (Imfinzi) and platinum-based chemotherapy for adult patients with metastatic non-small cell lung cancer with no sensitizing ...

Medical research

FDA approves immunotherapy for dMMR endometrial cancer

The anti-programmed death receptor 1 (PD-1) monotherapy Jemperli (dostarlimab) received approval for treatment of mismatch repair-deficient (dMMR) recurrent or advanced endometrial cancer that has progressed after treatment ...

Diseases, Conditions, Syndromes

WHO study finds remdesivir didn't help COVID-19 patients

A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the ...

Alzheimer's disease & dementia

Tauvid receives approval for tau pathology imaging

(HealthDay)—Tauvid (flortaucipir F18), a radioactive diagnostic agent, was approved to image tau pathology in patients with cognitive impairment being evaluated for Alzheimer disease, the U.S. Food and Drug Administration ...

page 2 from 7